Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography.
bladder cancer
computed tomography
machine learning
radiomics
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
30 Apr 2022
30 Apr 2022
Historique:
received:
31
03
2022
revised:
27
04
2022
accepted:
27
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Approximately 25% of the patients with muscle-invasive bladder cancer (MIBC) who are clinically node negative have occult lymph node metastases at radical cystectomy (RC) and pelvic lymph node dissection. The aim of this study was to evaluate preoperative CT-based radiomics to differentiate between pN+ and pN0 disease in patients with clinical stage cT2-T4aN0-N1M0 MIBC. Patients with cT2-T4aN0-N1M0 MIBC, of whom preoperative CT scans and pathology reports were available, were included from the prospective, multicenter CirGuidance trial. After manual segmentation of the lymph nodes, 564 radiomics features were extracted. A combination of different machine-learning methods was used to develop various decision models to differentiate between patients with pN+ and pN0 disease. A total of 209 patients (159 pN0; 50 pN+) were included, with a total of 3153 segmented lymph nodes. None of the individual radiomics features showed significant differences between pN+ and pN0 disease, and none of the radiomics models performed substantially better than random guessing. Hence, CT-based radiomics does not contribute to differentiation between pN+ and pN0 disease in patients with cT2-T4aN0-N1M0 MIBC.
Identifiants
pubmed: 35629148
pii: jpm12050726
doi: 10.3390/jpm12050726
pmc: PMC9147130
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Dutch Research Council
ID : 14929 - 14930
Pays : Netherlands
Organisme : European Union
ID : EuCanShare - Nr. 825903
Organisme : European Union
ID : EuCanImage - Nr. 952103
Références
Clin Cancer Res. 2017 Nov 15;23(22):6904-6911
pubmed: 28874414
J Urol. 2004 May;171(5):1823-8; discussion 1827-8
pubmed: 15076285
Eur Urol. 2010 Apr;57(4):641-7
pubmed: 19477579
J Urol. 2007 Aug;178(2):451-4
pubmed: 17561135
Eur Urol. 2012 May;61(5):1070-1
pubmed: 22336379
Radiology. 2010 Jan;254(1):31-46
pubmed: 20032141
Ann Surg Oncol. 2015 Sep;22(9):3150-6
pubmed: 25634779
Endocr Relat Cancer. 2021 Jun 21;28(8):529-539
pubmed: 34003139
Abdom Radiol (NY). 2019 May;44(5):1712-1721
pubmed: 30767041
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Curr Urol Rep. 2015 Apr;16(4):22
pubmed: 25724433
J Clin Oncol. 2011 Jun 1;29(16):2171-7
pubmed: 21502557
Radiographics. 2011 Jan-Feb;31(1):135-60
pubmed: 21257939
Eur Urol. 2012 May;61(5):1031-8
pubmed: 22196847
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Radiology. 1995 Dec;197(3):705-11
pubmed: 7480743
Mol Oncol. 2008 Aug;2(2):115-52
pubmed: 19383333
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Eur Urol Focus. 2019 Jan;5(1):90-96
pubmed: 28753817
Radiology. 2014 Oct;273(1):125-35
pubmed: 24893049
World J Urol. 2012 Dec;30(6):827-31
pubmed: 22198726
J Urol. 2003 Mar;169(3):943-5
pubmed: 12576818
J Digit Imaging. 2022 Apr;35(2):127-136
pubmed: 35088185
J Urol. 2000 Jun;163(6):1693-6
pubmed: 10799162
BMC Urol. 2015 Aug 21;15:87
pubmed: 26294219
Acta Radiol. 2021 Oct;62(10):1275-1282
pubmed: 33121263
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Urol Oncol. 2016 Apr;34(4):166.e1-6
pubmed: 26705102
J Clin Oncol. 2001 Feb 1;19(3):666-75
pubmed: 11157016
Radiology. 2003 May;227(2):371-7
pubmed: 12732695
J Cancer Sci Ther. 2012 Jul 30;S14(1):
pubmed: 23471167
J Am Coll Radiol. 2018 May;15(5S):S150-S159
pubmed: 29724418
AJR Am J Roentgenol. 2003 Apr;180(4):1045-54
pubmed: 12646453
Gend Med. 2008 Dec;5(4):385-94
pubmed: 19108811
Eur J Radiol. 2012 Nov;81(11):3124-30
pubmed: 22464844
Transl Androl Urol. 2018 Oct;7(5):804-813
pubmed: 30456183
J Clin Oncol. 1992 Jul;10(7):1066-73
pubmed: 1607913
Eur Urol. 2012 May;61(5):1039-47
pubmed: 22381169
Clin Exp Metastasis. 2021 Oct;38(5):483-494
pubmed: 34533669
Transl Androl Urol. 2018 Oct;7(5):783-803
pubmed: 30456182
BJU Int. 2005 Apr;95(6):786-90
pubmed: 15794783
J Urol. 2008 Jul;180(1):121-7
pubmed: 18485392
Eur Urol. 2021 Jan;79(1):82-104
pubmed: 32360052
Medicina (Kaunas). 2021 Mar 01;57(3):
pubmed: 33804350
J Clin Med. 2020 Jun 23;9(6):
pubmed: 32585894
ESMO Open. 2022 Apr;7(2):100416
pubmed: 35248823
Eur Urol. 2021 Feb;79(2):214-221
pubmed: 32868138
Eur Urol. 2010 Feb;57(2):205-11
pubmed: 19879039
Cancer Treat Rev. 2018 Nov;70:88-97
pubmed: 30125800
Cancer. 2011 Jan 15;117(2):276-82
pubmed: 20830767
Br J Surg. 2019 Dec;106(13):1800-1809
pubmed: 31747074
Cancer. 1989 Dec 15;64(12):2448-58
pubmed: 2819654
BJU Int. 2000 Jul;86 Suppl 1:111-22
pubmed: 10961281